President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

While the Trump administration has painted the jettisoning of staff and regulations as good for business, there are multiple ...

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Details about your health, medical history and prescriptions can all be found in your medical record. A new Canadian study ...

The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...